Suppr超能文献

根据KC 128和左沙丁胺醇的作用估算气道平滑肌中格列本脲敏感钾通道的区域和物种差异。

Regional and species differences in glyburide-sensitive K+ channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim.

作者信息

Kamei K, Yoshida S, Imagawa J, Nabata H, Kuriyama H

机构信息

Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co. Ltd., Shizuoka, Japan.

出版信息

Br J Pharmacol. 1994 Nov;113(3):889-97. doi: 10.1111/j.1476-5381.1994.tb17076.x.

Abstract
  1. The purpose of the present experiments was to elucidate the differences in actions of two K+ channel openers, KC 128 and levcromakalim, on the carbachol-induced contraction, membrane potential and 86Rb+ efflux of the dog tracheal and bronchial smooth muscles. Furthermore, we compared the effects of these agents on guinea-pig and human airway smooth muscles. 2. In the dog tracheal and bronchial smooth muscle tissues, levcromakalim induced a concentration-dependent relaxation of the carbachol-induced contraction. The IC50 values were 0.35 microM (pIC50: 6.46 +/- 0.10, n = 9) and 0.55 microM (pIC50: 6.26 +/- 0.07, n = 5), respectively. KC 128 relaxed bronchial smooth muscles precontracted by carbachol with an IC50 value of 0.19 microM (pIC50: 6.73 +/- 0.10, n = 7). However, KC 128 had almost no effect on the contraction evoked by carbachol in the trachea (IC50 > 10 microM). The relaxations induced by levcromakalim and KC 128 were antagonized by glyburide (0.03-1 microM) but not by charybdotoxin (100 nM). 3. Levcromakalim (1 microM) hyperpolarized the membrane of both dog tracheal and bronchial smooth muscle cells, whereas KC 128 (1 microM) hyperpolarized the membrane of bronchial but not of tracheal smooth muscle cells. 4. Levcromakalim (10 microM) increased 86Rb+ efflux rate from both tracheal and bronchial smooth muscle tissues but KC 128 (10 microM) increased 86Rb+ efflux rate only from bronchial and not tracheal smooth muscle tissues. Glyburide (1 microM) prevented the hyperpolarization and the 86Rb+ efflux induced by these agents at the same concentration as observed for mechanical responses. 5. Both KC 128 and levcromakalim relaxed the guinea-pig isolated tracheal smooth muscles precontracted by carbachol (100 nM), histamine (3 micro M) or U46619 (10 nM). KC 128 was approximately 10 times more potent than levcromakalim for each agonist.6. In human bronchial smooth muscles, levcromakalim but not KC 128 induced a concentration dependent relaxation of the carbachol-induced contraction.7. It is concluded that KC 128 has relaxant and hyperpolarizing effects in the dog bronchial and guinea-pig tracheal smooth muscles, but not in the dog tracheal and human bronchial smooth muscles.On the other hand, levcromakalim acts consistently on all the above airway smooth muscle tissues.These results indicate that there are regional and species differences in distribution of K+ channels, and at least two different K+ channel opener- and glyburide-sensitive K+ channels are present in the dog airway smooth muscles.
摘要
  1. 本实验的目的是阐明两种钾通道开放剂KC 128和左旋克罗卡林对犬气管和支气管平滑肌的卡巴胆碱诱导收缩、膜电位及⁸⁶Rb⁺外流的作用差异。此外,我们比较了这些药物对豚鼠和人气道平滑肌的作用。2. 在犬气管和支气管平滑肌组织中,左旋克罗卡林可诱导卡巴胆碱诱导收缩的浓度依赖性舒张。其半数抑制浓度(IC50)值分别为0.35微摩尔/升(pIC50:6.46±0.10,n = 9)和0.55微摩尔/升(pIC50:6.26±0.07,n = 5)。KC 128可舒张由卡巴胆碱预收缩的支气管平滑肌,IC50值为0.19微摩尔/升(pIC50:6.73±0.10,n = 7)。然而,KC 128对气管中卡巴胆碱诱发的收缩几乎无作用(IC50>10微摩尔/升)。左旋克罗卡林和KC 128诱导的舒张作用被格列本脲(0.03 - 1微摩尔/升)拮抗,但不被大蝎毒素(100纳摩尔/升)拮抗。3. 左旋克罗卡林(1微摩尔/升)使犬气管和支气管平滑肌细胞的膜发生超极化,而KC 128(1微摩尔/升)仅使支气管平滑肌细胞的膜超极化,对气管平滑肌细胞无此作用。4. 左旋克罗卡林(10微摩尔/升)可增加气管和支气管平滑肌组织的⁸⁶Rb⁺外流率,但KC 128(10微摩尔/升)仅增加支气管平滑肌组织的⁸⁶Rb⁺外流率,对气管平滑肌组织无此作用。格列本脲(1微摩尔/升)在与机械反应相同的浓度下可阻止这些药物诱导的超极化和⁸⁶Rb⁺外流。5. KC 128和左旋克罗卡林均可舒张由卡巴胆碱(100纳摩尔/升)、组胺(3微摩尔/升)或U46619(10纳摩尔/升)预收缩的豚鼠离体气管平滑肌。对于每种激动剂,KC 128的效力约为左旋克罗卡林的10倍。6. 在人支气管平滑肌中,左旋克罗卡林可诱导卡巴胆碱诱导收缩的浓度依赖性舒张,而KC 128无此作用。7. 得出结论:KC 128对犬支气管和豚鼠气管平滑肌有舒张和超极化作用,但对犬气管和人支气管平滑肌无此作用。另一方面,左旋克罗卡林对上述所有气道平滑肌组织均有一致作用。这些结果表明钾通道分布存在区域和物种差异,犬气道平滑肌中至少存在两种不同的钾通道开放剂和格列本脲敏感的钾通道。

相似文献

本文引用的文献

1
The pharmacology of ATP-sensitive potassium channels.ATP敏感性钾通道的药理学
Annu Rev Pharmacol Toxicol. 1993;33:597-637. doi: 10.1146/annurev.pa.33.040193.003121.
6
The pharmacology of potassium channels and their therapeutic potential.钾通道的药理学及其治疗潜力。
Trends Pharmacol Sci. 1988 Jan;9(1):21-8. doi: 10.1016/0165-6147(88)90238-6.
10
Structure-activity relationships of K+ channel openers.钾通道开放剂的构效关系
Trends Pharmacol Sci. 1990 Oct;11(10):417-22. doi: 10.1016/0165-6147(90)90149-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验